Literature DB >> 14700725

Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia.

R M Camicioli1, J R Korzan, S L Foster, N J Fisher, D J Emery, A C Bastos, C C Hanstock.   

Abstract

The basis for cognitive deficits in Parkinson's disease (PD) is unknown. Hippocampal atrophy has been shown in Alzheimer's disease (AD) and PD. N-Acetyl aspartate (NAA)/creatine (Cr) ratio in the posterior cingulate gyrus (PCG) is decreased in AD, but unknown in PD. Volumetric magnetic resonance (MR) imaging (at 1.5 T) determined corrected HC volume and MR spectroscopy (MRS) PCG metabolites in 12 non-demented mild to moderately affected PD patients (six male, six female) and ten controls (five male, five female). Age (PD=60.6 years, control=62.2; P=0.62), education (PD=14.1 years, controls=13.8; P=0.89) and global cognition (Mini-Mental State Exam score: PD=28.7, controls=29.6; P=0.14) did not differ. Only recall (CVLT-II, P=0.046) and NAA/Cr (PD=1.53, controls=1.78; P=0.03) were decreased in PD. Memory correlated with NAA/Cr (r=0.65, P=0.02) in PD. In conclusion, cingulate metabolic changes occur in PD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14700725     DOI: 10.1016/j.neulet.2003.09.076

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

Review 1.  Neuroimaging in Parkinson's disease.

Authors:  A Jon Stoessl
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia.

Authors:  Liana G Apostolova; Mona Beyer; Amity E Green; Kristy S Hwang; Jonathan H Morra; Yi-Yu Chou; Christina Avedissian; Dag Aarsland; Carmen C Janvin; Jan P Larsen; Jeffrey L Cummings; Paul M Thompson
Journal:  Mov Disord       Date:  2010-04-30       Impact factor: 10.338

3.  Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.

Authors:  Paul G Unschuld; Richard A E Edden; Aaron Carass; Xinyang Liu; Megan Shanahan; Xin Wang; Kenichi Oishi; Jason Brandt; Susan S Bassett; Graham W Redgrave; Russell L Margolis; Peter C M van Zijl; Peter B Barker; Christopher A Ross
Journal:  Mov Disord       Date:  2012-05-30       Impact factor: 10.338

4.  Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment.

Authors:  Liana Apostolova; Guido Alves; Kristy S Hwang; Sona Babakchanian; Kolbjorn S Bronnick; Jan Petter Larsen; Paul M Thompson; Yi-Yu Chou; Ole B Tysnes; Hege K Vefring; Mona K Beyer
Journal:  Neurobiol Aging       Date:  2011-08-03       Impact factor: 4.673

Review 5.  Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.

Authors:  Linda Chang; Sody M Munsaka; Stephanie Kraft-Terry; Thomas Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-12       Impact factor: 4.147

6.  White matter alteration of the cingulum in Parkinson disease with and without dementia: evaluation by diffusion tensor tract-specific analysis.

Authors:  K Kamagata; Y Motoi; O Abe; K Shimoji; M Hori; A Nakanishi; T Sano; R Kuwatsuru; S Aoki; N Hattori
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

7.  Identification of metabolic correlates of mild cognitive impairment in Parkinson's disease using magnetic resonance spectroscopic imaging and machine learning.

Authors:  Hakan Gurvit; Esin Ozturk-Isik; Sevim Cengiz; Dilek Betul Arslan; Ani Kicik; Emel Erdogdu; Muhammed Yildirim; Gokce Hale Hatay; Zeynep Tufekcioglu; Aziz Müfit Uluğ; Basar Bilgic; Hasmet Hanagasi; Tamer Demiralp
Journal:  MAGMA       Date:  2022-07-22       Impact factor: 2.533

8.  Neurofunctional characteristics of executive control in older people with HIV infection: a comparison with Parkinson's disease.

Authors:  Eva M Müller-Oehring; Jui-Yang Hong; Kathleen L Poston; Helen M Brontë-Stewart; Edith V Sullivan; Lawrence McGlynn; Tilman Schulte
Journal:  Brain Imaging Behav       Date:  2022-03-16       Impact factor: 3.224

9.  Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia.

Authors:  H Randall Griffith; Jan A den Hollander; Ozioma C Okonkwo; Timothy O'Brien; Ray L Watts; Daniel C Marson
Journal:  Alzheimers Dement       Date:  2008-11       Impact factor: 21.566

Review 10.  MR spectroscopy in neurodegenerative disease.

Authors:  W R Wayne Martin
Journal:  Mol Imaging Biol       Date:  2007 Jul-Aug       Impact factor: 3.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.